Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.

Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, Wang H, Chen J, Wang H.

PLoS One. 2011 Apr 29;6(4):e19495. doi: 10.1371/journal.pone.0019495.

PMID:
21559338
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phenotypical and functional specialization of FOXP3+ regulatory T cells.

Campbell DJ, Koch MA.

Nat Rev Immunol. 2011 Feb;11(2):119-30. doi: 10.1038/nri2916. Review.

PMID:
21267013
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity.

Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF, Shan Q, Zheng ZH, Liu CM, Wang YJ.

J Pathol. 2010 Oct;222(2):199-212. doi: 10.1002/path.2754.

PMID:
20690163
[PubMed - indexed for MEDLINE]
4.

Cancer statistics, 2010.

Jemal A, Siegel R, Xu J, Ward E.

CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):133-4.

PMID:
20610543
[PubMed - indexed for MEDLINE]
Free Article
5.

FOXP3+ regulatory T cells in the human immune system.

Sakaguchi S, Miyara M, Costantino CM, Hafler DA.

Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18. Review.

PMID:
20559327
[PubMed - indexed for MEDLINE]
6.

Regulatory T cells in tumor immunity.

Nishikawa H, Sakaguchi S.

Int J Cancer. 2010 Aug 15;127(4):759-67. doi: 10.1002/ijc.25429. Review.

PMID:
20518016
[PubMed - indexed for MEDLINE]
7.

Prognostic significance of regulatory T cells in tumor.

Wilke CM, Wu K, Zhao E, Wang G, Zou W.

Int J Cancer. 2010 Aug 15;127(4):748-58. doi: 10.1002/ijc.25464. Review.

PMID:
20473951
[PubMed - indexed for MEDLINE]
8.

Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.

Xu L, Xu W, Qiu S, Xiong S.

Clin Immunol. 2010 Jun;135(3):466-75. doi: 10.1016/j.clim.2010.01.014. Epub 2010 Feb 24.

PMID:
20181533
[PubMed - indexed for MEDLINE]
9.

Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.

Zhou J, Ding T, Pan W, Zhu LY, Li L, Zheng L.

Int J Cancer. 2009 Oct 1;125(7):1640-8. doi: 10.1002/ijc.24556.

PMID:
19569243
[PubMed - indexed for MEDLINE]
10.

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F.

Nat Immunol. 2009 May;10(5):514-23. doi: 10.1038/ni.1716. Epub 2009 Mar 22.

PMID:
19305396
[PubMed - indexed for MEDLINE]
11.

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, Biota C, Doffin AC, Durand I, Olive D, Perez S, Pasqual N, Faure C, Ray-Coquard I, Puisieux A, Caux C, Blay JY, Ménétrier-Caux C.

Cancer Res. 2009 Mar 1;69(5):2000-9. doi: 10.1158/0008-5472.CAN-08-2360. Epub 2009 Feb 24.

PMID:
19244125
[PubMed - indexed for MEDLINE]
Free Article
12.

CCR6 regulates the migration of inflammatory and regulatory T cells.

Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, Martin-Orozco N, Kang HS, Ma L, Panopoulos AD, Craig S, Watowich SS, Jetten AM, Tian Q, Dong C.

J Immunol. 2008 Dec 15;181(12):8391-401.

PMID:
19050256
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The immunosuppressive tumor microenvironment in hepatocellular carcinoma.

Pang YL, Zhang HG, Peng JR, Pang XW, Yu S, Xing Q, Yu X, Gong L, Yin YH, Zhang Y, Chen WF.

Cancer Immunol Immunother. 2009 Jun;58(6):877-86. doi: 10.1007/s00262-008-0603-5. Epub 2008 Oct 22.

PMID:
18941744
[PubMed - indexed for MEDLINE]
14.

Moving targets: cell migration inhibitors as new anti-inflammatory therapies.

Mackay CR.

Nat Immunol. 2008 Sep;9(9):988-98. doi: 10.1038/ni.f.210. Review.

PMID:
18711436
[PubMed - indexed for MEDLINE]
15.

Orchestrating the orchestrators: chemokines in control of T cell traffic.

Bromley SK, Mempel TR, Luster AD.

Nat Immunol. 2008 Sep;9(9):970-80. doi: 10.1038/ni.f.213. Review.

PMID:
18711434
[PubMed - indexed for MEDLINE]
16.

Chemokines and leukocyte traffic.

Sallusto F, Baggiolini M.

Nat Immunol. 2008 Sep;9(9):949-52. doi: 10.1038/ni.f.214.

PMID:
18711431
[PubMed - indexed for MEDLINE]
17.

How regulatory T cells work.

Vignali DA, Collison LW, Workman CJ.

Nat Rev Immunol. 2008 Jul;8(7):523-32. doi: 10.1038/nri2343. Review.

PMID:
18566595
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Regulatory T cells and immune tolerance.

Sakaguchi S, Yamaguchi T, Nomura T, Ono M.

Cell. 2008 May 30;133(5):775-87. doi: 10.1016/j.cell.2008.05.009. Review.

PMID:
18510923
[PubMed - indexed for MEDLINE]
Free Article
19.

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY.

J Clin Oncol. 2007 Jun 20;25(18):2586-93.

PMID:
17577038
[PubMed - indexed for MEDLINE]
Free Article
20.

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.

PMID:
17570208
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk